Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 4
1945 226
1946 753
1947 811
1948 918
1949 790
1950 1338
1951 1529
1952 1521
1953 1895
1954 2110
1955 2283
1956 2195
1957 2082
1958 2080
1959 2154
1960 2471
1961 2907
1962 3376
1963 4995
1964 7096
1965 5930
1966 6070
1967 7743
1968 9477
1969 11241
1970 12126
1971 13845
1972 14654
1973 15916
1974 16593
1975 16139
1976 15763
1977 16324
1978 16603
1979 18032
1980 17760
1981 18782
1982 20515
1983 22616
1984 24602
1985 26924
1986 27631
1987 28922
1988 29464
1989 31505
1990 32491
1991 32651
1992 32951
1993 32569
1994 33382
1995 33528
1996 33046
1997 32395
1998 33331
1999 33715
2000 35066
2001 35831
2002 35701
2003 37239
2004 38547
2005 41889
2006 42749
2007 44329
2008 45747
2009 47750
2010 49858
2011 52072
2012 51992
2013 52365
2014 52873
2015 52552
2016 51717
2017 51230
2018 51705
2019 52178
2020 57044
2021 61658
2022 60767
2023 51502
2024 16667

Text availability

Article attribute

Article type

Publication date

Search Results

1,864,808 results

Results by year

Filters applied: . Clear all
Page 1
Developments in Vaccine Adjuvants.
Firdaus FZ, Skwarczynski M, Toth I. Firdaus FZ, et al. Methods Mol Biol. 2022;2412:145-178. doi: 10.1007/978-1-0716-1892-9_8. Methods Mol Biol. 2022. PMID: 34918245 Review.
In this chapter, we review the adjuvants that are available for use in human vaccines, such as alum, MF59, AS03, and AS01. ...Additionally, we summarize recent trends in adjuvant discovery, providing a brief overview of saponins, TLRs agonists, polysaccharides, nanoparticl …
In this chapter, we review the adjuvants that are available for use in human vaccines, such as alum, MF59, AS03, and AS01. ...Additio …
Which immunomodulator?
James DG. James DG. Br J Clin Pract. 1991 Spring;45(1):53-6. Br J Clin Pract. 1991. PMID: 1718384 Review. No abstract available.
Editorial: The role of vitamin D as an immunomodulator.
Aribi M, Mennechet FJD, Touil-Boukoffa C. Aribi M, et al. Front Immunol. 2023 Mar 28;14:1186635. doi: 10.3389/fimmu.2023.1186635. eCollection 2023. Front Immunol. 2023. PMID: 37056773 Free PMC article. No abstract available.
New-age vaccine adjuvants, their development, and future perspective.
Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R, Johri AK. Verma SK, et al. Front Immunol. 2023 Feb 24;14:1043109. doi: 10.3389/fimmu.2023.1043109. eCollection 2023. Front Immunol. 2023. PMID: 36911719 Free PMC article. Review.
Hence, there is a great possibility of improving the potential of a vaccine in formulation with novel adjuvants, which can effectively impart superior immunity. The vaccine(s) in formulation with novel adjuvants may also be helpful in fighting pathogens of high anti …
Hence, there is a great possibility of improving the potential of a vaccine in formulation with novel adjuvants, which can effectivel …
Blood transfusions as an immunomodulator--a review.
Waymack JP, Alexander JW. Waymack JP, et al. Comp Immunol Microbiol Infect Dis. 1986;9(2-3):177-83. doi: 10.1016/0147-9571(86)90010-x. Comp Immunol Microbiol Infect Dis. 1986. PMID: 3539493 Review.
Prevention of this immunosuppression may be possible by the concomitant use of immunomodulators which inhibit suppressor T lymphocyte function or block prostaglandin E production. ...
Prevention of this immunosuppression may be possible by the concomitant use of immunomodulators which inhibit suppressor T lymphocyte …
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedside.
Wittig B, Schmidt M, Scheithauer W, Schmoll HJ. Wittig B, et al. Crit Rev Oncol Hematol. 2015 Apr;94(1):31-44. doi: 10.1016/j.critrevonc.2014.12.002. Epub 2014 Dec 19. Crit Rev Oncol Hematol. 2015. PMID: 25577571 Free article. Review.
Early clinical trials with CpG-ODN as TLR-9 agonists were associated with unfavorable tolerability and narrow clinical efficacy, leading to failure in pivotal trials. dSLIM, the active ingredient of MGN1703, is a DNA-based, radically different molecular alternative to CpG-ODN, wh …
Early clinical trials with CpG-ODN as TLR-9 agonists were associated with unfavorable tolerability and narrow clinical efficacy, leading to …
Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations.
Wang F, Su H, Wang Z, Anderson CF, Sun X, Wang H, Laffont P, Hanes J, Cui H. Wang F, et al. ACS Nano. 2023 Jun 13;17(11):10651-10664. doi: 10.1021/acsnano.3c01748. Epub 2023 May 22. ACS Nano. 2023. PMID: 37212741
Here, we report on the design and synthesis of a peptide-based supramolecular filament (SF) hydrogel as a universal carrier for localized delivery of three immunomodulating agents of distinct action mechanisms and different molecular weights, including an aPD1 antibody, an …
Here, we report on the design and synthesis of a peptide-based supramolecular filament (SF) hydrogel as a universal carrier for localized de …
1,864,808 results
You have reached the last available page of results. Please see the User Guide for more information.